Grants to Support Investigator-Initiated Early-Phase Clinical Trials in Vermont (USA)
GrantID: 64183
Grant Funding Amount Low: $250,000
Deadline: October 2, 2026
Grant Amount High: $1,515,000
Summary
The grant aims to accelerate the development of innovative treatments and diagnostic tools for heart, lung, blood, and sleep (HLBS) conditions. The program seeks to catalyze breakthroughs in HLBS research, ultimately improving patient outcomes and advancing medical knowledge...
Eligible Regions
Interests
Eligible Requirements
Grant Detailed Description
View Full Grant Details
Additional Criteria of Eligibility
Additional Funding in Information
Estimated Size of Grant
Contact Info
Funding Source
Overview
This grant is meant to financially support organizations or entities that focus their efforts on, but not limited to: Awards, Financial Assistance, Health & Medical, Higher Education, Municipalities, Non-Profit Support Services, Other, Research & Evaluation, Science, Technology Research & Development in Vermont (USA).